Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Condensed Consolidated Statements of Operations (Unaudited)

v3.23.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Income Statement [Abstract]        
Revenues $ 10,184 $ 66 $ 10,617 $ 132
Cost of revenues 615 43 940 74
Gross Profit 9,569 23 9,677 58
Operating expenses:        
Research and development 2,574 2,599 4,676 4,841
General, administrative and marketing 1,318 1,609 2,843 3,170
Operating income (loss) 5,677 (4,185) 2,158 (7,953)
Financial income (expenses), net 85 (100) (111) (192)
Net income (loss) for the period $ 5,762 $ (4,285) $ 2,047 $ (8,145)
Basic net income (loss) per ordinary share (in Dollars per share) $ 0.51 $ (0.39) $ 0.18 $ (0.74)
Diluted net income (loss) per ordinary share (in Dollars per share) $ 0.49 $ (0.39) $ 0.17 $ (0.74)
Weighted average ordinary shares outstanding used in computation of basic net income (loss) per share (in Shares) 11,369,031 11,086,481 11,329,516 10,935,611
Weighted average ordinary shares outstanding used in computation of diluted net income (loss) per share (in Shares) 11,777,139 11,086,481 11,738,884 10,935,611